Search
PainReform Ltd
PRFXAdd to Watchlist
1.360USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
225.93KMarket Cap
LossP/E TTM
More Details of PainReform Ltd Company
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
PainReform Ltd Info
Ticker SymbolPRFX
Company namePainReform Ltd
IPO dateSep 01, 2020
CEOHadar (Ilan)
Number of employees2
Security typeOrdinary Share
Fiscal year-endSep 01
Address65 Yigal Alon St.
CityTEL AVIV-YAFO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code6744316
Phone97237177051
Websitehttps://painreform.com/
Ticker SymbolPRFX
IPO dateSep 01, 2020
CEOHadar (Ilan)
Company Executives of PainReform Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Ilan Hadar
Mr. Ilan Hadar
Chief Executive Officer, Chief Financial Officer
Chief Executive Officer, Chief Financial Officer
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Sigal Aviel
Dr. Sigal Aviel
Chief Operating Officer
Chief Operating Officer
--
--
Mrs. Rita Keynan
Mrs. Rita Keynan
Vice President - Pharmaceutical Operations
Vice President - Pharmaceutical Operations
--
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Efi Cohen-Arazi
Mr. Efi Cohen-Arazi
Independent Director
Independent Director
--
--
Dr. Ellen S. Baron
Dr. Ellen S. Baron
Independent Director
Independent Director
--
--
Mr. Augustine J. (Gus) Lawlor
Mr. Augustine J. (Gus) Lawlor
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Ilan Hadar
Mr. Ilan Hadar
Chief Executive Officer, Chief Financial Officer
Chief Executive Officer, Chief Financial Officer
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Sigal Aviel
Dr. Sigal Aviel
Chief Operating Officer
Chief Operating Officer
--
--
Mrs. Rita Keynan
Mrs. Rita Keynan
Vice President - Pharmaceutical Operations
Vice President - Pharmaceutical Operations
--
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Efi Cohen-Arazi
Mr. Efi Cohen-Arazi
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of PainReform Ltd?
The top five shareholders of PainReform Ltd are: Mr. Ilan Hadar
How many institutions hold shares of PainReform Ltd (PRFX)?
As of 2026Q1, 16 institutions hold shares of PainReform Ltd, with a combined market value of approximately 15.73K, accounting for 1.84% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -4772.00.